From June 1, 2022 to August 31, 2022, the company has repurchased 46,464 shares, representing 0.55% for $0.27 million. With this, the company has completed the repurchase of 4,129,262 shares, representing 41.99% for $12.65 million under the buyback announced on December 12, 2011.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.04 USD | -3.02% |
|
+0.75% | +39.83% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.83% | 67.19M | |
+24.36% | 87.86B | |
-21.96% | 76.69B | |
+3.24% | 26.86B | |
+3.28% | 17.76B | |
-0.60% | 15.22B | |
+78.15% | 13.56B | |
+80.61% | 13.37B | |
-24.56% | 13.01B | |
+24.80% | 12.7B |
- Stock Market
- Equities
- CCEL Stock
- News Cryo-Cell International, Inc.
- Tranche Update on Cryo-Cell International, Inc.'s Equity Buyback Plan announced on December 12, 2011.